Health Catalyst Sees Q2 Sales $68.000M-$70.000M vs $70.752M Est

Benzinga Newsdesk www.benzinga.com Positive 82.5%

Neg 0% Neu 0% Pos 82.5%

Health Catalyst (NASDAQ:HCAT) sees Q2 sales of $68.000 million-$70.000 million vs $70.752 million analyst estimate.

Comments

No comments yet. Be the first!